Amicus Therapeutics Ownership | Who Owns Amicus Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Amicus Therapeutics Ownership Summary

Amicus Therapeutics is owned by 23.78% institutional investors, 0.69% insiders, and 75.54% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.96% of FOLD shares. Vanguard Health Care Inv is the top mutual fund, with 6.78% of its assets in Amicus Therapeutics shares.

FOLD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Amicus Therapeutics	23.78%	0.69%	75.54%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	33.88M	10.96%	$489.89M
Vanguard group	29.70M	9.63%	$422.97M
Blackrock	24.37M	8.05%	$241.77M
Ubs group	15.96M	5.16%	$230.75M
Avoro capital advisors	15.03M	4.88%	$118.40M
Pentwater capital management lp	14.00M	4.53%	$202.44M
State street	12.89M	4.17%	$186.45M
Glazer capital	12.72M	4.12%	$183.97M
Fil	12.56M	4.06%	$181.62M
Goldman sachs group	11.56M	3.74%	$167.10M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cibra capital	1.69M	11.78%	$24.40M
Chicago capital management	666.00K	5.99%	$7.23M
Psquared asset management	1.10M	5.54%	$15.92M
Versor investments lp	136.07K	4.82%	$1.97M
Gardner lewis asset management l p	1.41M	4.43%	$20.46M
Glazer capital	12.72M	3.90%	$183.97M
Vestal point capital, lp	9.75M	3.47%	$76.83M
Athos capital	695.50K	3.10%	$10.06M
P schoenfeld asset management lp	363.00K	2.85%	$5.25M
Tig advisors	3.83M	2.56%	$55.32M

Top Buyers

Holder	Shares	% Assets	Change
Fil	12.56M	0.14%	11.60M
Glazer capital	12.72M	3.90%	11.12M
Ubs group	15.96M	0.03%	10.06M
Goldman sachs group	11.56M	0.02%	5.41M
Millennium management	7.91M	0.05%	4.91M

Top Sellers

Holder	Shares	% Assets	Change
Bellevue group	-	-	-10.74M
William blair investment management	-	-	-10.63M
Hbk investments l p	8.78M	1.29%	-6.47M
Perceptive advisors	-	-	-6.37M
Soleus capital management	-	-	-5.21M

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	2.14M	0.01%	2.14M	$30.93M
Nexpoint asset management	2.04M	1.98%	2.04M	$29.49M
Iron triangle partners lp	1.97M	2.21%	1.97M	$15.53M
Gardner lewis asset management l p	1.41M	4.43%	1.41M	$20.46M
Norges bank	1.17M	0.00%	1.17M	$16.59M

Sold Out

Holder	Change
Skopos labs	-22.00
Clearstead advisors	-33.00
Cva family office	-43.00
Capital performance advisors llp	-43.00
Svb wealth	-44.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	126	-63.90%	73,477,308	-77.10%	23	0.22%	56	-72.95%	35	-58.82%
Dec 31, 2025	205	-33.01%	174,980,941	-44.00%	56	0.55%	121	-25.77%	45	-49.44%
Sep 30, 2025	166	-39.19%	134,937,657	-54.68%	43	0.47%	101	-32.21%	43	-46.25%
Jun 30, 2025	279	-4.78%	319,193,520	4.06%	103	1.04%	152	0.66%	81	-3.57%
Mar 31, 2025	293	-2.98%	309,463,718	1.44%	100	1.00%	152	2.01%	83	-17.82%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	20.89M	6.78%	-
Vanguard Total Stock Mkt Idx Inv	10.04M	3.20%	259.50K
Vanguard US Total Market Shares ETF	9.38M	3.05%	10.28K
Vanguard Small Cap Index	7.25M	2.31%	240.68K
iShares Russell 2000 ETF	7.22M	2.30%	-58.94K
BlackRock Event Driven Equity Instl	6.08M	1.94%	-
State Street® SPDR® S&P® Biotech ETF	5.90M	1.88%	88.76K
Macquarie Small Cap Core I	5.62M	1.82%	614.64K
Delaware Small Cap Core I	5.13M	1.73%	-31.80K
SPDR® S&P Biotech ETF	5.04M	1.64%	124.19K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 02, 2026	Campbell Bradley L	President and CEO	Sell	$322.84K
Jan 20, 2026	Campbell Bradley L	President and CEO	Sell	$1.07M
Dec 19, 2025	Clark David Michael	Chief People Officer	Sell	$363.38K
Dec 15, 2025	Campbell Bradley L	President and CEO	Sell	$846.01K
Dec 15, 2025	Clark David Michael	Chief People Officer	Sell	$282.07K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	2
2025 Q4	-	10
2025 Q3	-	-
2025 Q2	-	-

FOLD Ownership FAQ

Who Owns Amicus Therapeutics?

Amicus Therapeutics shareholders are primarily institutional investors at 23.78%, followed by 0.69% insiders and 75.53% retail investors. The average institutional ownership in Amicus Therapeutics's industry, Biotech Stocks , is 35.75%, which Amicus Therapeutics falls below.

Who owns the most shares of Amicus Therapeutics?

Amicus Therapeutics’s largest shareholders are Blackrock funding, inc. /de (33.88M shares, 10.96%), Vanguard group (29.7M shares, 9.63%), and Blackrock (24.37M shares, 8.05%). Together, they hold 28.64% of Amicus Therapeutics’s total shares outstanding.

Does Blackrock own Amicus Therapeutics?

Yes, BlackRock owns 8.05% of Amicus Therapeutics, totaling 24.37M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 241.77M$. In the last quarter, BlackRock increased its holdings by 1.52M shares, a 6.66% change.

Who is Amicus Therapeutics’s biggest shareholder by percentage of total assets invested?

Cibra capital is Amicus Therapeutics’s biggest shareholder by percentage of total assets invested, with 11.78% of its assets in 1.69M Amicus Therapeutics shares, valued at 24.4M$.

Who is the top mutual fund holder of Amicus Therapeutics shares?

Vanguard Health Care Inv is the top mutual fund holder of Amicus Therapeutics shares, with 6.78% of its total shares outstanding invested in 20.89M Amicus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools